INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• Utilizing Curated Data To Boost Your Urology Research And Innovation

  Obtain robust data from a reputable source to boost your urology research and propel your life science company's innovation in the urology space.

• Harnessing R Shiny Dashboards For Statistical Programming And Data Visualization

  Empower your teams to move beyond static reports by leveraging R Shiny to transform data into interactive, real-time insights that drive smarter, faster decisions.

• The Strategic Advantage Of eCOA And IRT

  The future lies in unified, interoperable eCOA–IRT solutions that streamline operations, improve data integrity, and enhance patient and site experience.

• Demystifying AI: The Fundamentals And Applications In Drug Development

  Explore the history of AI, gain clarity on key concepts, address common questions, and discover its transformative role in drug development, with insights into its current and future impact on the industry.

• Perspective On The FDA's Final Digital Health Technologies Guidance

  1/24/2024

  Review the final release of "Digital Health Technologies for Remote Data Acquisition in Clinical Investigations”, where the FDA acknowledges DHT value and the increasing use of them in clinical trials.

• Virtual eConsent For Decentralized Trials

  12/23/2025

  Virtual eConsent improves accessibility and compliance in decentralized trials, streamlining enrollment with a secure, user-friendly process for informed consent in remote research.

• The Synergistic Role Of Drug Safety In Clinical Trial Operations

  4/25/2024

  Delve into the significance of adept interpersonal leadership within your drug safety program, shedding light on the operational and financial benefits that stem from fostering a collaborative environment.

• How Sponsors Can Drive Success With Central eSource At Investigator Sites

  6/17/2025

  Centralized eSource systems enable complex clinical trials to align with key regulatory frameworks, including ICH E6(R3), ICH E8(R1), and 21 CFR 312, to meet the highest standards of GCP.

• Why ePROs In Oncology Are Perfect For Capturing The Patient's Voice

  5/15/2025

  Recently released FDA guidance showcases why electronic patient-reported outcomes (ePROs) are ideal for capturing the “voice” of the patient. See how ePRO eases oncology trials.